Zollinger-ellison Syndrome
📧 Sign up to get email alerts when something new happens for Zollinger-ellison Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-24Clinical Trial Update: Evaluating Pancreatic Tumors in Patients With Zollinger-Ellison Syndrome
This is a completed clinical trial evaluating pancreatic tumors in patients with Zollinger-Ellison syndrome.
-
FDA approval · 2025-05-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Devatis Inc.)
FDA approves Pantoprazole Sodium as an Original Application generic product from Devatis Inc. under ANDA 215074.
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s pantoprazole sodium delayed-release granules as an original generic pantoprazole product (ANDA 217458) for aci…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for pantoprazole sodium injection, adding a new generic injectable panto…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pantoprazole Sodium from Aurobindo Pharma Limited, making a generic pantoprazole available. The pr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original abbreviated new drug application for pantoprazole sodium from Rising Pharma Holdings, enabling the generic pro…
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for lansoprazole submitted by NorthStar Rx LLC.
-
FDA approval · 2024-12-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium from Ascend Laboratories, LLC, under an approved ANDA.
-
FDA approval · 2024-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC, updating the approval for this generic prot…
-
FDA approval · 2024-11-12FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for esomeprazole magnesium from Mylan Pharmaceuticals, enabling the generic product to be marketed w…
-
FDA approval · 2024-11-08FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
FDA approval · 2024-11-07FDA Approved: CIMETIDINE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s Original Application for cimetidine, enabling the marketing of a generic H2 blocker. The action establishes a…
-
FDA approval · 2024-11-04FDA Approved: LANSOPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic version of lansoprazole via an Original Abbreviated New Drug Application for Macleods Pharmaceuticals Limited.
-
FDA approval · 2024-10-23FDA Approved: ESOMEPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Esomeprazole under an Original Application for Macleods' generic product, enabling generic market access.
-
FDA approval · 2024-08-01FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Fresenius Kabi USA, LLC)
FDA approved Pantoprazole sodium from Fresenius Kabi USA as an original application (ANDA) generic product.
-
FDA approval · 2024-07-17FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for esomeprazole magnesium by Somerset Therapeutics, LLC.
-
FDA approval · 2024-07-05FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for Lansoprazole from Mylan Pharmaceuticals Inc. under an existing ANDA, approving a generic version…
-
FDA approval · 2024-05-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
FDA approves a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Inc., authorizing changes to an existing generic prod…
-
FDA approval · 2024-05-03FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole from Mylan Pharmaceuticals Inc., indicating an amendment to the approved generic pr…
-
FDA approval · 2024-04-15FDA Approved: PANTOPRAZOLE SODIUM I.V. — Supplemental Application (Piramal Critical Care)
The FDA approved a supplemental application for Pantoprazole Sodium for Injection (IV), submitted by Piramal Critical Care, enabling its con…
-
FDA approval · 2024-04-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Edenbridge Pharmaceuticals LLC.)
FDA approved a supplemental application for pantoprazole sodium from Edenbridge Pharmaceuticals LLC., indicating an approved modification un…
-
FDA approval · 2024-03-05FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Eugia US LLC)
FDA approved a supplemental application for pantoprazole sodium submitted by Eugia US LLC.
-
FDA approval · 2024-02-14FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Baxter Healthcare Corporation)
FDA approved Baxter's original application for pantoprazole sodium in 0.9% sodium chloride. It is a proton pump inhibitor used to treat acid…
-
FDA approval · 2024-02-14FDA Approved: LANSOPRAZOLE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for lansoprazole filed by Mylan Pharmaceuticals (ANDA 090763).
-
FDA approval · 2024-02-05FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Esomeprazole Magnesium submitted by Zydus Pharmaceuticals USA Inc., enabling the generic esomepr…